An Alternative Approach to Current Guidelines: The Use of Top-Up Long-Acting Buprenorphine Injection for A Patient Presenting with Withdrawal Symptoms
1. Abstract A 34-year-old male patient with opioid use disorder (OUD), who was transitioned from daily oral buprenorphine/naloxone therapy.